1007P cfDNA and ctDNA variations are predictive of disease progression to conventional transarterial chemoembolization (cTACE) in patients with hepatocellular carcinoma (HCC)

Autor:	F. Di Fiore, Thierry Frebourg, Ludivine Beaussire, L. Schwarz, N. Sarafan Vasseur, Pierre Michel, J-J. Tuech, Ghassan Riachi, Odile Goria, V. Verdier, David Sefrioui, C. Savoye-Collet, Alice Gangloff, Hélène Montialoux, S. Ghomadi
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Hepatocellular carcinoma Disease progression medicine In patient Hematology medicine.disease business
Zdroj:	Annals of Oncology. 31:S698
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2020.08.1123
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b00299f05c8276fa96dafd0264fa3b10 https://doi.org/10.1016/j.annonc.2020.08.1123 Zobrazit plný text záznamu